scispace - formally typeset
Journal ArticleDOI

The structural basis of herpesvirus entry.

TLDR
In this Review, Connolly, Jardetzky and Longnecker discuss recent insights into herpesvirus entry by analysing the structures of entry glycoproteins, including the diverse receptor-binding glyCoproteins and conserved fusion proteins.
Abstract
Herpesviruses are ubiquitous, double-stranded DNA, enveloped viruses that establish lifelong infections and cause a range of diseases. Entry into host cells requires binding of the virus to specific receptors, followed by the coordinated action of multiple viral entry glycoproteins to trigger membrane fusion. Although the core fusion machinery is conserved for all herpesviruses, each species uses distinct receptors and receptor-binding glycoproteins. Structural studies of the prototypical herpesviruses herpes simplex virus 1 (HSV-1), HSV-2, human cytomegalovirus (HCMV) and Epstein–Barr virus (EBV) entry glycoproteins have defined the interaction sites for glycoprotein complexes and receptors, and have revealed conformational changes that occur on receptor binding. Recent crystallography and electron microscopy studies have refined our model of herpesvirus entry into cells, clarifying both the conserved features and the unique features. In this Review, we discuss recent insights into herpesvirus entry by analysing the structures of entry glycoproteins, including the diverse receptor-binding glycoproteins (HSV-1 glycoprotein D (gD), EBV glycoprotein 42 (gp42) and HCMV gH–gL–gO trimer and gH–gL–UL128–UL130–UL131A pentamer), as well gH–gL and the fusion protein gB, which are conserved in all herpesviruses. Recent crystallography and electron microscopy studies have refined our model of herpesvirus entry into cells. In this Review, Connolly, Jardetzky and Longnecker discuss recent insights into herpesvirus entry by analysing the structures of entry glycoproteins, including the diverse receptor-binding glycoproteins and conserved fusion proteins.

read more

Citations
More filters
Journal ArticleDOI

The healthy human virome: from virus–host symbiosis to disease

TL;DR: In this article, the authors attempt to delineate the healthy human virome, that is, the entirety of viruses that are present in a healthy human body, and the bulk of the healthy virome consists of bacteriophages infecting bacteria in the intestine.
Journal ArticleDOI

Cytomegalovirus Infection and Inflammation in Developing Brain

TL;DR: In this paper, the authors provide an overview of the cytomegalovirus infection in the brain, local immune response to infection, and mechanisms leading to the development of CNS sequelae.
Posted ContentDOI

A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus.

TL;DR: A potent neutralizing antibody is identified as a promising candidate for prophylactic and therapeutic interventions against EBV infection by binding to a key vulnerable interface between the D-I/D-II domains of the viral gH/gL protein.
Journal ArticleDOI

Flavonoids Target Human Herpesviruses That Infect the Nervous System: Mechanisms of Action and Therapeutic Insights

TL;DR: Insight is lent into the recent advances that have been achieved during the past five years in utilizing flavonoids as promising natural drugs for the treatment of HHVs infections of the nervous system such as alpha-herpesviruses (herpes simplex virus type 1, type 2, and varicella-zoster virus), beta- herpesvirus (human cytomegalovirus), and gamma-herpeviruses.
Journal ArticleDOI

Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers.

TL;DR: In this article, the authors comprehensively compiles all studies that have featured anti-HOHV properties of BBR along with promising preventive effects against the associated cancers, including mechanisms and pathways induced by BBR via targeting the herpesvirus life cycle and the pathogenesis of the linked malignancies.
References
More filters
Journal ArticleDOI

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

TL;DR: The zoster vaccine markedly reduced morbidity from herpes zoster and postherpetic neuralgia among older adults and significantly reduced the burden of illness due to herpesZoster.
PatentDOI

Herpes simplex virus 1 entry into cells mediated by a novel member of the tnf/ngf receptor family

TL;DR: HVEM, the first identified mediator of HSV entry, is a new member of the TNF/NGF receptor family and showed to mediate the entry of several wild-type HSV strains of both serotypes.
Journal ArticleDOI

A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry

TL;DR: It is shown that heparan sulfate modified by a subset of the multiple D-glucosaminyl 3-O-sulfotransferase isoforms provides sites for the binding of a third viral glycoprotein, gD, and for initiation of HSV-1 entry.
Journal ArticleDOI

Entry of Alphaherpesviruses Mediated by Poliovirus Receptor-Related Protein 1 and Poliovirus Receptor

TL;DR: HveC, a human member of the immunoglobulin superfamily, was shown to mediate entry of several alphaherpesviruses, including herpes simplex viruses (HSV) 1 and 2, porcine pseudorabies virus (PRV), and bovine herpesvirus 1 (BHV-1).
Journal ArticleDOI

Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme.

TL;DR: Viral fusion proteins convert from a fusion-competent state to a membrane-embedded homotrimeric prehairpin, and then to a trimer-of-hairpins that brings the fusion peptide and the transmembrane domain into close proximity thereby facilitating the union of viral and target membranes.
Related Papers (5)